Sector | Trading | Compare with Sector peers |
Industry | Trading | Compare with Industry peers |
Website | http://www.evoqremedies.com | |
Market Cap | 14.27 Cr. | |
Enterprise Value(EV) | 15.54 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.19 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 8.81 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 65.05 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 18.22 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 0.58 | Calculated using Price: 10.49 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.36 Cr. | 13,600,000 Shares |
FaceValue | 10 | |
About EVOQ Remedies Ltd. | ||
The company specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices. |
1 Day |
|
+0.10% |
1 Week |
|
-0.57% |
1 Month |
|
+4.27% |
3 Month |
|
-22.81% |
6 Month |
|
-26.80% |
1 Year |
|
-21.42% |
2 Year |
|
-31.88% |
5 Year |
|
|
10 Year |
|
5 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 49.78 | 1.34 | 186.89 | 9.13 | 6.75 | |
Return on Capital Employed (%) | 68.94 | 2.69 | 246.9 | 9.12 | 6.96 | |
Return on Assets (%) | 0.52 | 0.01 | 10.45 | 5.27 | 4.75 |
Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 0 | 0 | 1 | 23 | 25 | 25 | |
Non Curr. Liab. | 0 | ||||||
Curr. Liab. | 2 | 6 | 7 | 10 | 10 | 6 | |
Minority Int. | |||||||
Equity & Liab. | 2 | 6 | 8 | 33 | 35 | 31 | |
Non Curr. Assets | 0 | 0 | |||||
Curr. Assets | 2 | 6 | 8 | 33 | 35 | 31 | |
Misc. Exp. not W/O | |||||||
Total Assets | 2 | 6 | 8 | 33 | 35 | 31 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Net Sales | 3 | 9 | 10 | 17 | 20 | |
Other Income | 6 | |||||
Total Income | 3 | 9 | 10 | 17 | 26 | |
Total Expenditure | -3 | -9 | -9 | -15 | -24 | |
PBIDT | 0 | 1 | 1 | 2 | ||
Interest | ||||||
Depreciation | ||||||
Taxation | 0 | 0 | -1 | |||
Exceptional Items | ||||||
PAT | 0 | 1 | 1 | 2 | ||
Adjusted EPS | 10 | 1 | 1 |
Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | -26 | -4 | |
Cash Fr. Inv. | 0 | |||||
Cash Fr. Finan. | 29 | 1 | ||||
Net Change | 0 | 0 | 0 | 3 | -3 | |
Cash & Cash Eqvt | 0 | 0 | 3 | 0 |
Mon, 15 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Submission of Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for the Quarter ended on 31st March 2024. |
Thu, 11 Apr 2024
Clarification Sought On Significant Movement In Price Clarification Sought on Significant movement in price. |
Thu, 04 Apr 2024
Clarification sought from Evoq Remedies Ltd The Exchange has sought clarification from Evoq Remedies Ltd on April 4 2024 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited. |
Fri, 26 Apr 2024 |
High Delivery Percentage |
Opening at High |
Opening at High for 3 days |
Opening at High for 2 Days |
High Increase in 1 Month |